Through the combination of significant organic growth and our unique M&A strategy, the Clanwilliam portfolio has expanded to 19 brands, 1050 employees and revenues of ~€90m.
Our investment strategy is driven by much more than gaining a return on investment.
We’ve built a collaborative healthcare group through combining a portfolio of high value, respected brands with a powerful and knowledgeable leadership team – empowered Managing Directors supported by our strategic C-Suite.
Individually, our products and services have their own unique story which contributes directly to our global mission, but each also embodies what it means to be Clanwilliam and our overarching drivers and goals.
Our strategy has remained deliberately focused, building a portfolio of likeminded and aligned companies with expert knowledge within their fields, of their customers, and of the future requirements of health and care.